FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced a proposed public offering of up to 5,000,000 shares of its common stock. All shares in the offering will be offered by Replimune. In addition, Replimune... More

